ZHEJIANG JIUZHOU PHARMACEU

Zhejiang Jiuzhou Pharmaceutical Holds Steady: 2026 Market Snapshot and Peer Comparison

Zhejiang Jiuzhou Pharmaceutical’s shares hold steady at CNH 16.10, amid a flat market and peer consolidation, offering a snapshot of its API focus and 3.36% YTD drop.

ZHEJIANG JIUZHOU PHARMACEU
China
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

Jake Connors

23/10/2026, 06:55

2 minutes to read

Jiangzhou Pharmaceutical Q3 2026 Earnings: Resilient Growth, Strong Balance Sheet, and Upside Potential

Explore Zhejiang Jiuzhou Pharma’s Q3 2026 earnings: modest revenue drop, resilient profit, growing R&D, and promising 2027 outlook for investors in China’s pharma sector.

ZHEJIANG JIUZHOU PHARMACEU
China
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

Samantha Roth

22/10/2026, 19:32

3 minutes to read

Zhejiang Jiuzhou Pharma’s Q3 Earnings, Share‑Buyback Boost, and Flat Market Performance

Explore Zhejiang Jiuzhou Pharmaceutical’s latest stock move, earnings briefing, and share‑repurchase plan—insights on value, market context, and future outlook.

ZHEJIANG JIUZHOU PHARMACEU
China
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

Jake Connors

21/10/2026, 19:12

3 minutes to read